Augmedix's device-based remote scribing system announces $19M Series B

Augmedix, a startup that uses natural language processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and other unnamed investors all contributed. Founded in 2012, the startup made a name for itself by outfitting doctors with Google Glass devices. Through these, professional medical scribes could remotely observe the visit and, with the help of NLP, fill out the patient's necessary documentation. This approach allows the clinician to remained focused on engaging their patient, only needing to sign off on or make minor adjustments to the documentation at the end of the visit.